🔎 Trials Near Me

Hjem › Geografisk atrofi › Ohio

Geografisk atrofi kliniske forsøg i Ohio

7 studier for Geografisk atrofi søger deltagere på steder i Ohio.

Byer i Ohio

Officiel studietekst (engelsk)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Cincinnati Eye Institute, Cincinnati
  • Cleveland Clinic Main Campus, Cleveland
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Retina Associates of Cleveland - Beachwood, Beachwood
  • Retina Associates of Cleveland, Cleveland
  • Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
RekruttererFase 1/2
Alder 55 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07029945

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Cincinnati Eye Institute, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Ohio State University, Columbus
  • og 1 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Retina Associates of Cleveland, Beachwood
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06662162

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Cleveland Clinic | Cole Eye Institute, Cleveland
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.